Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension

E-ISSN： 1751-7176|20|1|143-149

ISSN： 1524-6175

Source： The Journal of Clinical Hypertension, Vol.20, Iss.1, 2018-01, pp. : 143-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits and pitfalls of sacubitril/valsartan treatment in patients with hypertension

The Journal of Clinical Hypertension, Vol. 20, Iss. 2, 2018-02 ,pp. : 351-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nebivolol Monotherapy in Younger Adults (Younger Than 55 Years) With Hypertension: A Randomized, Placebo‐Controlled Trial

The Journal of Clinical Hypertension, Vol. 15, Iss. 9, 2013-09 ,pp. : 687-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 150-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sacubitril/valsartan instead of renin‐angiotensin system inhibition alone: A step forward in resistant hypertension

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 65-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

ASSESSING THE PROPORTIONALITY OF THE SINGLE TRANSFERABLE VOTE

By Farrell David M. Katz Richard S.

Representation, Vol. 50, Iss. 1, 2014-01 ,pp. : 13-26

Routledge Ltd

Access to resources Recommend Favorite